Select for export The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2010.10.002 PubMed 21126732 Copy citation Copy BibTeX Biological Psychiatry 2010-12-02 Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousness Other More
Select for export Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/archgenpsychiatry.2010.116 PubMed 20819978 Copy citation Copy BibTeX Archives of General Psychiatry 2010-09-05 Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL Europe PMC Published psilocybin DepressionAnxietyAging Other More
Select for export Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.ijpsycho.2008.05.397 Copy citation Copy BibTeX International Journal of Psychophysiology 2008-07-16 F.X. Vollenweider, Daniel Hell, Michael Kometer OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Psychophysische Korrelationen unter der Einwirkung von Psycholytika (LSD, Psilocybin und ähnl.) No abstract availability was recorded for this entry. Details DOI 10.1159/000135082 Copy citation Copy BibTeX Medicina Experimentalis 2008-05-20 H. Holfeld OpenAlex Published psilocybin Pharmacology Other More
Select for export Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85-100 No abstract availability was recorded for this entry. Details DOI 10.1159/000131192 Copy citation Copy BibTeX Psychiatria et Neurologia 2008-05-05 H. Heimann OpenAlex Published psilocybin General Other More
Select for export Klinische Erfahrungen mit Psilocybin (CY39 Sandoz) No abstract availability was recorded for this entry. Details DOI 10.1159/000131157 Copy citation Copy BibTeX Psychiatria et Neurologia 2008-05-05 M. Sercl, J Kovarik, O. Jaros OpenAlex Published psilocybin General Other More
Select for export Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69-84 No abstract availability was recorded for this entry. Details DOI 10.1159/000131191 Copy citation Copy BibTeX Psychiatria et Neurologia 2008-05-05 H Heimann OpenAlex Published psilocybin General Other More
Select for export Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder No abstract availability was recorded for this entry. Details DOI 10.1016/s0084-3970(08)70820-x Copy citation Copy BibTeX Yearbook of Psychiatry and Applied Mental Health 2007-12-31 J.C. Ballenger OpenAlex Published psilocybin OCDPharmacologySafety Other More
Select for export Psilocybin Results Inspire Researchers No abstract availability was recorded for this entry. Details DOI 10.1016/s0270-6644(07)70405-8 Copy citation Copy BibTeX Clinical Psychiatry News 2007-06-30 TIMOTHY F. KIRN OpenAlex Published psilocybin General Other More
Select for export Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4088/jcp.v67n1110 PubMed 17196053 Copy citation Copy BibTeX The Journal of Clinical Psychiatry 2006-10-31 Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Europe PMC Published psilocybin AnxietyOCDChronic Pain Other More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0461-9 Copy citation Copy BibTeX Psychopharmacology 2006-07-05 Herbert D. Kleber OpenAlex Published psilocybin SpiritualityMystical Experience Other More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0460-x Copy citation Copy BibTeX Psychopharmacology 2006-07-05 Charles R. Schuster OpenAlex Published psilocybin SpiritualityMystical Experience Other More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0459-3 Copy citation Copy BibTeX Psychopharmacology 2006-07-05 Solomon H. Snyder OpenAlex Published psilocybin SpiritualityMystical Experience Other More
Select for export Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-916185 PubMed 16342002 Copy citation Copy BibTeX Pharmacopsychiatry 2005-10-31 Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M Europe PMC Published psilocybin Receptor PharmacologyHealthy Volunteers Other More
Select for export Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-918695 Copy citation Copy BibTeX Pharmacopsychiatry 2005-08-31 Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eurpsy.2005.04.008 PubMed 15963699 Copy citation Copy BibTeX European Psychiatry 2005-07-31 Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export 177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia No abstract availability was recorded for this entry. Details DOI 10.1016/s0006-3223(00)00439-x Copy citation Copy BibTeX Biological Psychiatry 2000-03-31 Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Skinner, Maslow, and Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00221678930333005 Copy citation Copy BibTeX Journal of Humanistic Psychology 1993-06-30 Robert S. Gable OpenAlex Published psilocybin End-of-Life DistressConsciousness Other More
Select for export A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts* Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/schbul/3.4.560 PubMed 271353 Copy citation Copy BibTeX Schizophrenia Bulletin 1976-12-31 J.E. Kleinman, J. Christian Gillin, Richard Jed Wyatt OpenAlex Published psilocybin Review Article Review Article More
Select for export Underlying mechanism of psilocybin induced psychosis No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Acta Universitatis Palackianae Olomucensis Facultatis Medicae 1974-07-04 Jan Kolařı́k OpenAlex Published psilocybin General Other More
